Stryker Corp (SYK)

$383.72 +1.93 (0.51%)
Market Cap 145.96B
Revenue (ttm) 22.60B
Net Income (ttm) 2.99B
EPS (ttm) N/A
PE Ratio 29.81
Forward PE 28.38
Profit Margin 13.25%
Debt to Equity Ratio 0.78
Volume 1,179,928
Avg Vol 1,306,410
Day's Range N/A - N/A
Shares Out 382.31M
Stochastic %K 62%
Beta 0.94
Analysts Strong Sell
Price Target $434.56

Company Profile

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the t...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
patrickhuxley
patrickhuxley Oct. 27 at 8:56 PM
$LOW $SYK Locked chips https://stocktwits.com/jacobvirginia2/message/633847328
0 · Reply
OliviaAte
OliviaAte Oct. 27 at 4:57 PM
$SYK
0 · Reply
primohaywood
primohaywood Oct. 26 at 5:38 PM
$LOW $SYK Gap filling https://stocktwits.com/colindequincey/message/633715093
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Oct. 24 at 5:21 PM
$SYK holding since 2022 💪💪💪
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 10:42 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $12.10 - $13.60 Take Profit: $27.59 Stop Bleeding: $10.65 ROI Potential: 128% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 4:59 PM
Barclays has adjusted their stance on Stryker ( $SYK ), setting the rating to Overweight with a target price of 443 → 453.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 22 at 2:18 PM
$SYK RSI: 69.98, MACD: 0.6836 Vol: 6.26, MA20: 370.99, MA50: 378.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:01 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $11.40 - $11.50 Take Profit: $22.31 Stop Bleeding: $10.12 ROI Potential: 94% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 4:57 PM
3 wide-moat winners to watch for Q4 🔥 $MCO, $SYK and $CBRE are spotlighted for their strong growth forecasts and strategic expansions — a combo that could strengthen any portfolio’s resilience this quarter. See why these names could enhance Q4 returns 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-teaser-16944&ADID=SYND_STOCKTWITS_TWEET_2_2772986_TEASER_16944
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 2:06 PM
Why $MCO, $SYK, & $CBRE are top Wide Moat picks! 🏰 Moody's, Stryker, and CBRE each boast a Zacks Rank #2 (Buy) for the current quarter, highlighting their strategic advantages and resilience. With strong growth drivers—like MCO's acquisitions, SYK's product innovation, and CBRE's diversified model—these stocks are well-positioned for sustained performance. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-body-16864&ADID=SYND_STOCKTWITS_TWEET_2_2772986_BODY_16864
0 · Reply
Latest News on SYK
It's time to scoop up undervalued stocks in this critical sector of the economy

Oct 21, 2025, 11:07 AM EDT - 6 days ago

It's time to scoop up undervalued stocks in this critical sector of the economy

BSX ISRG BDX BDYN BIO FEGE JGLO

Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025

Oct 14, 2025, 8:10 AM EDT - 13 days ago

Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025

Stryker to announce financial results for its third quarter of fiscal year 2025

Oct 1, 2025, 8:00 AM EDT - 26 days ago

Stryker to announce financial results for its third quarter of fiscal year 2025

Stryker Launches Incompass Total Ankle System at AOFAS 2025

Sep 9, 2025, 7:20 AM EDT - 6 weeks ago

Stryker Launches Incompass Total Ankle System at AOFAS 2025

Stryker Corporation (SYK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 4, 2025, 5:33 PM EDT - 7 weeks ago

Stryker Corporation (SYK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Stryker Q2: Record Mako Installation And High Utilization

Aug 19, 2025, 2:55 PM EDT - 2 months ago

Stryker Q2: Record Mako Installation And High Utilization

Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares

Aug 19, 2025, 1:50 PM EDT - 2 months ago

Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares

Stryker to host investor day

Aug 15, 2025, 8:00 AM EDT - 2 months ago

Stryker to host investor day

Stryker to participate in the 2025 Wells Fargo Securities Healthcare Conference

Aug 14, 2025, 8:00 AM EDT - 2 months ago

Stryker to participate in the 2025 Wells Fargo Securities Healthcare Conference

Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital

Aug 7, 2025, 2:20 PM EDT - 2 months ago

Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital

Stryker declares an $0.84 per share quarterly dividend

Aug 7, 2025, 8:00 AM EDT - 2 months ago

Stryker declares an $0.84 per share quarterly dividend

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:59 PM EDT - 3 months ago

Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript

Stryker raises annual profit forecast on steady demand for surgical devices

Jul 31, 2025, 4:55 PM EDT - 3 months ago

Stryker raises annual profit forecast on steady demand for surgical devices

Stryker reports second quarter 2025 operating results

Jul 31, 2025, 4:05 PM EDT - 3 months ago

Stryker reports second quarter 2025 operating results

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 3 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY PODD

Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases

Jul 29, 2025, 9:07 AM EDT - 3 months ago

Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases

North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies

Jul 11, 2025, 5:07 AM EDT - 3 months ago

North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies

Stryker to announce financial results for its second quarter of fiscal year 2025

Jul 1, 2025, 8:00 AM EDT - 4 months ago

Stryker to announce financial results for its second quarter of fiscal year 2025

The Big 3: NXT, ANET, SYK

Jun 26, 2025, 1:01 PM EDT - 4 months ago

The Big 3: NXT, ANET, SYK

ANET NXT

Stryker receives FDA clearance for Incompass Total Ankle System

Jun 25, 2025, 8:15 AM EDT - 4 months ago

Stryker receives FDA clearance for Incompass Total Ankle System

The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

Jun 3, 2025, 11:09 AM EDT - 5 months ago

The 3 Most Overvalued Stocks Top Managers Are Selling in 2025

MA NFLX

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

May 19, 2025, 1:01 PM EDT - 5 months ago

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Baron Opportunity Fund Q1 2025 Top Contributors And Detractors

May 15, 2025, 8:05 AM EDT - 5 months ago

Baron Opportunity Fund Q1 2025 Top Contributors And Detractors

AMZN AVGO CSGP MSFT NVDA SPOT TSLA

Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)

May 13, 2025, 8:23 PM EDT - 5 months ago

Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)

Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)

May 9, 2025, 5:42 PM EDT - 6 months ago

Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)

Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker

May 5, 2025, 2:20 PM EDT - 6 months ago

Final Trades: Rockwell Automation, Alerian MLP, Lockheed Martin and Stryker

LMT ROK AMLP

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:28 PM EDT - 6 months ago

Stryker Corporation (SYK) Q1 2025 Earnings Call Transcript

Stryker beats quarterly estimates of string medical device demand

May 1, 2025, 6:33 PM EDT - 6 months ago

Stryker beats quarterly estimates of string medical device demand

Stryker reports first quarter 2025 operating results

May 1, 2025, 4:05 PM EDT - 6 months ago

Stryker reports first quarter 2025 operating results

Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

Apr 29, 2025, 8:00 AM EDT - 6 months ago

Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

Apr 1, 2025, 4:26 PM EDT - 7 months ago

Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

Stryker completes sale of U.S. spinal implants business

Apr 1, 2025, 4:05 PM EDT - 7 months ago

Stryker completes sale of U.S. spinal implants business

Stryker announces intention to nominate Manny Maceda to board of directors

Mar 26, 2025, 10:15 AM EDT - 7 months ago

Stryker announces intention to nominate Manny Maceda to board of directors

Stryker announces Annual Meeting of Shareholders

Mar 25, 2025, 4:15 PM EDT - 7 months ago

Stryker announces Annual Meeting of Shareholders

The Big 3: MMM, PM, SYK

Mar 18, 2025, 1:01 PM EDT - 7 months ago

The Big 3: MMM, PM, SYK

MMM PM

Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

Mar 11, 2025, 8:03 AM EDT - 8 months ago

Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

Mar 6, 2025, 1:36 PM EST - 8 months ago

Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

Stryker launches Steri-Shield 8 personal protection system

Mar 4, 2025, 8:07 AM EST - 8 months ago

Stryker launches Steri-Shield 8 personal protection system

Stryker launches Sync Badge

Mar 3, 2025, 8:07 AM EST - 8 months ago

Stryker launches Sync Badge

Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)

Feb 28, 2025, 5:24 PM EST - 8 months ago

Stryker Corporation (SYK) Citi's 2025 Unplugged Medtech and Life Sciences Access Day (Transcript)

The Big 3: FTNT, NXT, SYK

Feb 20, 2025, 12:14 PM EST - 8 months ago

The Big 3: FTNT, NXT, SYK

FTNT NXT

Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

Feb 19, 2025, 8:30 AM EST - 8 months ago

Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

Kadant Set to Join S&P SmallCap 600

Feb 13, 2025, 5:54 PM EST - 9 months ago

Kadant Set to Join S&P SmallCap 600

KAI

Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

Feb 13, 2025, 8:00 AM EST - 9 months ago

Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

Stryker announces Allan Golston will retire from Board of Directors

Feb 10, 2025, 4:05 PM EST - 9 months ago

Stryker announces Allan Golston will retire from Board of Directors

Sales Growth, Strategic Acquisitions Drive Stryker Higher

Jan 31, 2025, 4:34 PM EST - 9 months ago

Sales Growth, Strategic Acquisitions Drive Stryker Higher

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Jan 29, 2025, 1:48 PM EST - 9 months ago

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript

Jan 28, 2025, 9:34 PM EST - 9 months ago

Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript

Stryker forecasts 2025 profit above estimates on robust demand for surgical devices

Jan 28, 2025, 5:33 PM EST - 9 months ago

Stryker forecasts 2025 profit above estimates on robust demand for surgical devices

Overlooked Stock: SYK

Jan 28, 2025, 4:45 PM EST - 9 months ago

Overlooked Stock: SYK

patrickhuxley
patrickhuxley Oct. 27 at 8:56 PM
$LOW $SYK Locked chips https://stocktwits.com/jacobvirginia2/message/633847328
0 · Reply
OliviaAte
OliviaAte Oct. 27 at 4:57 PM
$SYK
0 · Reply
primohaywood
primohaywood Oct. 26 at 5:38 PM
$LOW $SYK Gap filling https://stocktwits.com/colindequincey/message/633715093
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Oct. 24 at 5:21 PM
$SYK holding since 2022 💪💪💪
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 10:42 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $12.10 - $13.60 Take Profit: $27.59 Stop Bleeding: $10.65 ROI Potential: 128% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 4:59 PM
Barclays has adjusted their stance on Stryker ( $SYK ), setting the rating to Overweight with a target price of 443 → 453.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 22 at 2:18 PM
$SYK RSI: 69.98, MACD: 0.6836 Vol: 6.26, MA20: 370.99, MA50: 378.98 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:01 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $11.40 - $11.50 Take Profit: $22.31 Stop Bleeding: $10.12 ROI Potential: 94% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 4:57 PM
3 wide-moat winners to watch for Q4 🔥 $MCO, $SYK and $CBRE are spotlighted for their strong growth forecasts and strategic expansions — a combo that could strengthen any portfolio’s resilience this quarter. See why these names could enhance Q4 returns 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-teaser-16944&ADID=SYND_STOCKTWITS_TWEET_2_2772986_TEASER_16944
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 2:06 PM
Why $MCO, $SYK, & $CBRE are top Wide Moat picks! 🏰 Moody's, Stryker, and CBRE each boast a Zacks Rank #2 (Buy) for the current quarter, highlighting their strategic advantages and resilience. With strong growth drivers—like MCO's acquisitions, SYK's product innovation, and CBRE's diversified model—these stocks are well-positioned for sustained performance. Discover the full investment case here 👉 https://www.zacks.com/stock/news/2772986/buy-3-wide-moat-stocks-to-enhance-your-portfolio-returns-in-q4?cid=sm-stocktwits-2-2772986-body-16864&ADID=SYND_STOCKTWITS_TWEET_2_2772986_BODY_16864
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 10:20 PM
Enter: $SYK NOV 21 2025 $390 CALLS Buy in Price: $8.18 - $8.40 Take Profit: $13.25 Stop Bleeding: $7.20 ROI Potential: 62% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 8:20 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.90 Take Profit: $17.58 Stop Bleeding: $8.18 ROI Potential: 89% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 7:19 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.90 Take Profit: $16.00 Stop Bleeding: $8.18 ROI Potential: 72% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
StockAutoPro
StockAutoPro Oct. 18 at 6:21 AM
$SYK: Buy target $366.84 Sell target $387.28 Strong quarterly earnings suggest potential growth in the medical equipment manufacturing sector.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 11:39 PM
Enter: $SYK NOV 21 2025 $380 CALLS Buy in Price: $9.30 - $10.80 Take Profit: $17.86 Stop Bleeding: $8.18 ROI Potential: 92% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
TechTraderGrok
TechTraderGrok Oct. 16 at 10:38 PM
Sold $SYK at $369.11 (+1.1%). From Grok: "Exiting long SYK position as the downtrend persists with price below EMA and SMA, mirroring the August capitulation bounce that faded into losses, while avoiding hold through upcoming earnings on 10/30/2025 without qualifying positive history." https://www.techtrader.ai/grokwall/?post=15245&utm_source=dlvr.it&utm_medium=stocktwits
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 7:31 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $13.90 - $14.00 Take Profit: $18.62 Stop Bleeding: $12.32 ROI Potential: 33% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 2:10 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $13.90 - $14.00 Take Profit: $18.62 Stop Bleeding: $12.32 ROI Potential: 33% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 4:02 PM
Truist Securities has updated their rating for Stryker ( $SYK ) to Hold with a price target of 407.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 1:09 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $14.00 - $15.50 Take Profit: $25.34 Stop Bleeding: $12.32 ROI Potential: 81% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 14 at 1:19 AM
Enter: $SYK NOV 21 2025 $370 CALLS Buy in Price: $10.70 - $12.90 Take Profit: $21.51 Stop Bleeding: $9.42 ROI Potential: 101% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 13 at 10:05 PM
$SYK Share Price: $364.80 Contract Selected: Jan 16, 2026 $360 Calls Buy Zone: $17.34 – $21.42 Target Zone: $30.82 – $37.67 Potential Upside: 68% ROI Time to Expiration: 94 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply